Sulfonamide cannabinoid agonists and antagonists

Billy R Martin; Raj K Razdan; Roger Guy Pertwee

Sulfonamide cannabinoid agonists and antagonists

Billy R Martin (Inventor), Raj K Razdan (Inventor), Roger Guy Pertwee (Inventor)

Medical Sciences

Research output: Patent

Abstract

Cannabinoid agonists and antagonists are provided for use in the treatment of disorders such as acute and chronic pain, inflammation, loss of appetite, convulsions, multiple sclerosis, nausea and vomiting. The cannabinoid agonists and antagonists contain a sulfonamide moiety incorporated into the cannabinoid side chain, and the side chain itself may be saturated or unsaturated.

Original language	English
Patent number	US2005096379
IPC	C07D311/80; C07D311/00
Publication status	Published - 5 May 2005

Cite this

@misc{cf43380f376e441a8fec65a263d6b266,

title = "Sulfonamide cannabinoid agonists and antagonists",

abstract = "Cannabinoid agonists and antagonists are provided for use in the treatment of disorders such as acute and chronic pain, inflammation, loss of appetite, convulsions, multiple sclerosis, nausea and vomiting. The cannabinoid agonists and antagonists contain a sulfonamide moiety incorporated into the cannabinoid side chain, and the side chain itself may be saturated or unsaturated. ",

author = "Martin, {Billy R} and Razdan, {Raj K} and Pertwee, {Roger Guy}",

year = "2005",

month = may,

day = "5",

language = "English",

type = "Patent",

note = "US2005096379; C07D311/80; C07D311/00",

}

TY - PAT

T1 - Sulfonamide cannabinoid agonists and antagonists

AU - Martin, Billy R

AU - Razdan, Raj K

AU - Pertwee, Roger Guy

PY - 2005/5/5

Y1 - 2005/5/5

N2 - Cannabinoid agonists and antagonists are provided for use in the treatment of disorders such as acute and chronic pain, inflammation, loss of appetite, convulsions, multiple sclerosis, nausea and vomiting. The cannabinoid agonists and antagonists contain a sulfonamide moiety incorporated into the cannabinoid side chain, and the side chain itself may be saturated or unsaturated.

AB - Cannabinoid agonists and antagonists are provided for use in the treatment of disorders such as acute and chronic pain, inflammation, loss of appetite, convulsions, multiple sclerosis, nausea and vomiting. The cannabinoid agonists and antagonists contain a sulfonamide moiety incorporated into the cannabinoid side chain, and the side chain itself may be saturated or unsaturated.

M3 - Patent

M1 - US2005096379

ER -

Sulfonamide cannabinoid agonists and antagonists

Abstract

Fingerprint

Cite this